Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for Clinicians
Open Forum Infectious Diseases · 28.03.2024 · 11 (4)
DOI: 10.1093/ofid/ofae128 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 15.03.2024. Verfasst von Christo Cimino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Nontuberculous mycobacteria (NTM) can cause a variety of infections, including serious pulmonary disease. Treatment encompasses polypharmacy, with a targeted regimen of 2–5 active medications, depending on site of infection, species, and clinical characteristics. Medications may include oral, intravenous, and inhalational routes. Medication acquisition can be challenging for numerous reasons, including investigational status, limited distribution models, and insurance prior authorization. Additionally, monitoring and managing adverse reactions and drug interactions is a unique skill set. While NTM is primarily medically managed, clinicians may not be familiar with the intricacies of medication selection, procurement, and monitoring. This review offers insights into the pharmacotherapeutic considerations of this highly complex disease state, including regimen design, medication acquisition, safety monitoring, relevant drug–drug interactions, and adverse drug reactions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pharmacy, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
- Pharmacy Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
- Department of Clinical Pharmacy, School of Pharmacy and Section of Infectious Diseases, School of Medicine, West Virginia University, Morgantown, West Virginia, USA.
- Department of Pharmacy, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
ORCID-Profile: Christo Cimino, Christina G Rivera, Jeffrey C Pearson, Benjamin Colton, Douglas Slain, Monica V Mahoney
Zitieren
APA
Cimino, C., Rivera, C. G., Pearson, J. C., Colton, B., Slain, D., & Mahoney, M. V. (2024). Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for Clinicians. Open Forum Infectious Diseases, 11(4). https://doi.org/10.1093/ofid/ofae128
Vancouver
Cimino C, Rivera CG, Pearson JC, Colton B, Slain D, Mahoney MV. Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for Clinicians. Open Forum Infectious Diseases. 2024;11(4). doi:10.1093/ofid/ofae128
BibTeX
@article{Cimino2024,
author = {Cimino, Christo and Rivera, Christina G and Pearson, Jeffrey C and Colton, Benjamin and Slain, Douglas and Mahoney, Monica V},
title = {Pharmacotherapeutic Considerations in the Treatment of Nontuberculous Mycobacterial Infections: A Primer for Clinicians},
journal = {Open Forum Infectious Diseases},
year = {2024},
volume = {11},
number = {4},
doi = {10.1093/ofid/ofae128}
}
EUVIMED